Opening Asia for Russia

In the Russian Federation will begin testing a single vaccine against influenza and COVID-19

11.10.2021 40 просмотров

Clinical trials of a single vaccine against influenza and coronavirus will begin at the end of 2022, director of the Gamaleya Center Alexander Gintsburg told the Izvestia newspaper, Day.Az reports with reference to Gazeta.ru. 


According to the Russian scientist, the technological platform of the new drug will consist of a hybrid vaccine against rotavirus and various variants of coronavirus.

"If the new platform recommends itself well, we plan to switch to the option of combining influenza hemagglutinin antigens and, accordingly, S -proteins of the coronavirus,” he said.

The hybrid vaccine is designed to reduce mortality while being infected with these diseases.

Новости партнёров